[go: up one dir, main page]

NO961906L - Fremgangsmåte ved fremstilling av et klodronatpreparat - Google Patents

Fremgangsmåte ved fremstilling av et klodronatpreparat

Info

Publication number
NO961906L
NO961906L NO961906A NO961906A NO961906L NO 961906 L NO961906 L NO 961906L NO 961906 A NO961906 A NO 961906A NO 961906 A NO961906 A NO 961906A NO 961906 L NO961906 L NO 961906L
Authority
NO
Norway
Prior art keywords
clodronate
pct
preparation
tetrahydrate
disodium
Prior art date
Application number
NO961906A
Other languages
English (en)
Other versions
NO312938B1 (no
NO961906D0 (no
Inventor
Esko Pohjala
Heikki Nupponen
Kari Lehmussaari
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of NO961906D0 publication Critical patent/NO961906D0/no
Publication of NO961906L publication Critical patent/NO961906L/no
Publication of NO312938B1 publication Critical patent/NO312938B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ceramic Products (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Seasonings (AREA)
  • Glanulating (AREA)
  • Glass Compositions (AREA)
  • Detergent Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Peptides Or Proteins (AREA)
NO19961906A 1993-11-12 1996-05-10 Fremgangsmåte ved fremstilling av et klodronatpreparat NO312938B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI935019A FI94926C (fi) 1993-11-12 1993-11-12 Menetelmä klodronaattivalmisteen valmistamiseksi
PCT/FI1994/000509 WO1995013054A1 (en) 1993-11-12 1994-11-11 Process for preparing a clodronate preparation

Publications (3)

Publication Number Publication Date
NO961906D0 NO961906D0 (no) 1996-05-10
NO961906L true NO961906L (no) 1996-05-23
NO312938B1 NO312938B1 (no) 2002-07-22

Family

ID=8538945

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19961906A NO312938B1 (no) 1993-11-12 1996-05-10 Fremgangsmåte ved fremstilling av et klodronatpreparat

Country Status (25)

Country Link
US (1) US5776499A (no)
EP (1) EP0727983B1 (no)
JP (1) JPH09504800A (no)
KR (1) KR100352155B1 (no)
CN (1) CN1040945C (no)
AT (1) ATE202700T1 (no)
AU (1) AU679586B2 (no)
CA (1) CA2175994A1 (no)
CZ (1) CZ286132B6 (no)
DE (1) DE69427648T2 (no)
DK (1) DK0727983T3 (no)
ES (1) ES2160688T3 (no)
FI (1) FI94926C (no)
GR (1) GR3036470T3 (no)
HU (1) HU220633B1 (no)
IL (1) IL111596A (no)
NO (1) NO312938B1 (no)
NZ (1) NZ275833A (no)
PL (1) PL176658B1 (no)
PT (1) PT727983E (no)
RU (1) RU2141323C1 (no)
SK (1) SK280552B6 (no)
TW (1) TW436297B (no)
WO (1) WO1995013054A1 (no)
ZA (1) ZA948974B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
AR021347A1 (es) * 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
RO121891B1 (ro) 2001-07-04 2008-07-30 Sindan S.R.L. Compoziţie farmaceutică pentru profilaxia şi tratamentul dereglărilor metabolismului calciului şi procedeu de preparare
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
GB0616794D0 (en) 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
US10815558B2 (en) * 2015-12-22 2020-10-27 Stock Company “Chepetsky Mechanical Plant” (SC CMP) Method for preparing rods from titanium-based alloys
AU2018372762B2 (en) 2017-11-22 2025-08-21 Inbiomotion S.L. Therapeutic treatment of breast cancer based on c-maf status
TWI806467B (zh) 2022-03-03 2023-06-21 金兆豐數位科技股份有限公司 金融商品提昇報酬率多維度決策方法
IT202300007269A1 (it) 2023-04-14 2024-10-14 Univ Degli Studi Magna Graecia Di Catanzaro Formulazione farmaceutica composta da Peptide-C associato a un bisfosfonato in forma unica e suo uso nel trattamento dell’osteosarcopenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275468B1 (de) * 1986-12-20 1991-02-06 Roche Diagnostics GmbH Clodronat-haltige Arzneimittel und Verfahren zur Herstellung derselben
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
CZ287984B6 (cs) * 1993-05-15 2001-03-14 Roche Diagnostics Gmbh Tableta se zlepšenou biodostupností účinné látky, kyseliny klodronové, a způsob její výroby

Also Published As

Publication number Publication date
TW436297B (en) 2001-05-28
CZ132796A3 (en) 1996-10-16
CZ286132B6 (cs) 2000-01-12
NO312938B1 (no) 2002-07-22
GR3036470T3 (en) 2001-11-30
FI935019A0 (fi) 1993-11-12
CN1040945C (zh) 1998-12-02
JPH09504800A (ja) 1997-05-13
DE69427648D1 (de) 2001-08-09
PT727983E (pt) 2001-11-30
FI935019L (fi) 1995-05-13
ATE202700T1 (de) 2001-07-15
FI94926C (fi) 1995-11-27
PL176658B1 (pl) 1999-07-30
HU220633B1 (hu) 2002-03-28
NO961906D0 (no) 1996-05-10
KR100352155B1 (ko) 2002-12-31
IL111596A (en) 1998-12-06
RU2141323C1 (ru) 1999-11-20
ES2160688T3 (es) 2001-11-16
CA2175994A1 (en) 1995-05-18
AU8108794A (en) 1995-05-29
US5776499A (en) 1998-07-07
FI94926B (fi) 1995-08-15
PL314299A1 (en) 1996-09-02
IL111596A0 (en) 1995-01-24
DE69427648T2 (de) 2002-04-18
DK0727983T3 (da) 2001-09-24
WO1995013054A1 (en) 1995-05-18
AU679586B2 (en) 1997-07-03
ZA948974B (en) 1995-11-21
HUT75228A (en) 1997-04-28
HU9601257D0 (en) 1996-07-29
CN1134664A (zh) 1996-10-30
EP0727983B1 (en) 2001-07-04
KR960705548A (ko) 1996-11-08
EP0727983A1 (en) 1996-08-28
SK60696A3 (en) 1997-02-05
SK280552B6 (sk) 2000-03-13
NZ275833A (en) 1997-10-24

Similar Documents

Publication Publication Date Title
GR3031936T3 (en) Process for preparing controlled release pharmaceutical forms and the forms thus obtained.
UA37214C2 (uk) Таблетки, що диспергуються у воді, та спосіб їх виготовлення
IL115309A0 (en) Pharmaceutical preparation containing metformin and processes for the production thereof
NO971965D0 (no) Farmasöytisk preparat inneholdende en smeltbar bærer og fremgangsmåte for fremstilling derav
NO961906D0 (no) Fremgangsmåte ved fremstilling av et klodronatpreparat
HUT44128A (en) Process for producing substituted pyrimidines and pesticide compositions containing them as active components
NZ500664A (en) Process for making flurbiprofen lozenges by granulating flubiprofen with a bulking agent (selected from calcium carbonate, tricalcium phosphate or microcrystalline cellulose)
MY113718A (en) Pharmaceutical formulation containing a hydrophobic active substance and an effervescent system, and process for the preparation of the formulation
ATE59960T1 (de) Theophyllintabletten mit verzoegerter freigabe.
HUT49793A (en) Herbicide compositions containing n-aryl-tetrahydro-phtalimides as active components and process for producing the active components
GB2124078B (en) Processes for preparing tablets by a modified wet-granulation technique
JPS5296729A (en) Mixed vaccin for cyanomycosis
ES2113408T3 (es) Procedimiento para preparar una composicion detergente granular.
HUT52763A (en) Herbicide and growth-controlling compositions containing sulfonyl-urea derivatives as active components and process for producing the active components
JPS5299207A (en) Remedy for cattle diarrhea
IL91986A0 (en) 2-azabicyclo(2.2.1)hept-5-ene-2-acetic acid,derivatives thereof and related compounds,process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
JPS57170165A (en) Active calcium fortifier
FR2703262B1 (fr) Mélanges gazeux.
JPS53122679A (en) Process for preparing forming tablets
DK260387D0 (da) Soenderdelingsapparat til tilvejebringelse af pastaagtige masser, isaer poelsemasse
DE3372765D1 (en) Carbamic-acid esters, process and starting material for their preparation, parasiticides containing these esters as active products, as well as the use of such esters and agents in combating parasites
JPS53104724A (en) Preparation of uniform hbsag particles
HUT52781A (en) Process for producing new isomeres of dideoxynucleosides and pharmaceutical compositions containing them as active components
RU94018502A (ru) Способ получения гербицидных гранулированных продуктов
JPS55105881A (en) Buffer memory system